Insulin Lispro · Humalog

Peptide

Approvedregulatory verdict

Evidence outlook

Approved: Type 2 Diabetes, Type 1 Diabetes

Regulatory approval supersedes design-level evidence grading; the trials behind approval are preserved below as the drug's evidence history.

track record: Reliable signal

Also approved (2)
JP
  • Diabetes mellitus requiring insulin therapy
Product first approved 2001PMDA
EU
  • Treatment of adults and children with diabetes mellitus who require insulin
Product first approved 1996EMA

How the evidence outlook works ↗

All registered studies

Every ClinicalTrials.gov study of this drug's own program. Studies backing a featured trial above are marked Featured; the rest aren't individually graded. Filter by which indication a study was run for, then browse by phase. Studies where this drug served as another program's comparator, or is merely referenced, are listed separately below.

Phase 3 (38)
Type 1 Diabetes
NCT03952130 · Eli Lilly and Company
2019-05-29 – 2022-01-10 · Type 1 Diabetes Mellitus
What this study did
NCT03740919 · Eli Lilly and Company
2019-04-07 – 2021-07-02 · Type 1 Diabetes Mellitus
What this study did
NCT03338023 · Eli Lilly and Company
2018-03-23 – 2020-03-05 · Type 1 Diabetes
What this study did
NCT03830281 · Eli Lilly and Company
2019-02-14 – 2020-01-06 · Type 1 Diabetes Mellitus
What this study did
NCT03214367 · Eli Lilly and Company
2017-07-17 – 2019-08-22 · Type 1 Diabetes Mellitus
What this study did
NCT03433677 · Eli Lilly and Company
2018-02-21 – 2018-09-04 · Diabetes Type 1
What this study did
NCT01481779 · Eli Lilly and Company
2012-01 – 2014-06 · Diabetes Mellitus, Type 1
What this study did
NCT01792284 · Eli Lilly and Company
2013-02 – 2014-04 · Type 1 Diabetes Mellitus
What this study did
NCT01421147 · Eli Lilly and Company
2011-08 – 2013-04 · Diabetes Mellitus, Type 1
What this study did
NCT00993473 · Sanofi
2009-10 – 2011-03 · Type 1 Diabetes Mellitus
What this study did
NCT00487240 · Eli Lilly and Company
2007-06 – 2008-08 · Diabetes Mellitus, Type 1
What this study did
NCT00046501 · Sanofi
2002-11 – 2005-02 · Diabetes Mellitus
What this study did
Type 2 Diabetes
NCT05462756 · Eli Lilly and Company
2022-08-11 – 2024-02-27 · Type 2 Diabetes, Type 2 Diabetes Treated With Insulin
What this study did
NCT03952143 · Eli Lilly and Company
2019-05-27 – 2021-01-20 · Type 2 Diabetes Mellitus
What this study did
NCT03214380 · Eli Lilly and Company
2017-07-14 – 2019-03-13 · Type 2 Diabetes Mellitus
What this study did
NCT02229227 · GlaxoSmithKline
2014-11-21 – 2017-07-24 · Diabetes Mellitus, Type 2
What this study did
NCT01621178 · Eli Lilly and Company
2012-07 – 2016-12 · Type 2 Diabetes, Chronic Kidney Disease
What this study did
NCT01023165 · Global Infusion and Aspiration Systems, LLC
2009-11 – 2015-11 · Diabetes Mellitus, Metabolic Integrity
What this study did
NCT01468987 · Eli Lilly and Company
2011-12 – 2013-08 · Diabetes Mellitus, Type 2
What this study did
NCT01191268 · Eli Lilly and Company
2010-11 – 2012-09 · Diabetes Mellitus, Type 2
What this study did
NCT00976391 · GlaxoSmithKline
2009-09 – 2012-05 · Diabetes Mellitus, Type 2
What this study did
NCT00666718 · Eli Lilly and Company
2008-04 – 2010-02 · Diabetes Mellitus, Type 2
What this study did
NCT00560417 · Eli Lilly and Company
2007-11 – 2009-12 · Diabetes Mellitus, Type 2
What this study did
NCT00510952 · Eli Lilly and Company
2007-08 – 2008-10 · Diabetes Mellitus, Type 2
What this study did
NCT00494013 · Eli Lilly and Company
2007-08 – 2008-09 · Diabetes Mellitus Type 2
What this study did
NCT00231725 · Eli Lilly and Company
2005-09 – 2006-04 · Type 2 Diabetes Mellitus
What this study did
Other / comorbidity
NCT03507829 · Medical University of Vienna
2012-11-21 – 2018-05-22 · Hyperglycemia
What this study did
NCT01680185 · Medical University of Vienna
2012-08 – 2018-05 · Hyperglycemia
What this study did
NCT01454284 · Eli Lilly and Company
2012-01 – 2014-02 · Diabetes Mellitus, Type 1
What this study did
NCT01398670 · Wockhardt
2012-02 – 2013-05 · Type I Diabetes
What this study did
NCT01134107 · Eli Lilly and Company
2010-11 – 2011-12 · Diabetes Mellitus, Type 1
What this study did
NCT01136746 · Eli Lilly and Company
2011-03 – 2011-11 · Hyperglycemia
What this study did
NCT01109316 · Eli Lilly and Company
2010-04 – 2011-08 · Diabetes Mellitus, Type 1
What this study did
NCT00700622 · Mannkind Corporation
2008-05 – 2010-03 · Diabetes, Type 1
What this study did
NCT00097071 · Novo Nordisk A/S
2004-10 – 2006-05 · Diabetes, Diabetes Mellitus, Type 1
What this study did
NCT00071448 · Novo Nordisk A/S
2002-06 – 2004-06 · Diabetes, Diabetes Mellitus, Type 1
What this study did
Phase 2/3 (2)
Type 1 Diabetes
NCT03262116 · Massachusetts General Hospital
2019-03-19 – 2019-07-23 · Type 1 Diabetes Mellitus
What this study did
Type 2 Diabetes
NCT00228904 · Florida Atlantic University
2005-02 – 2011-10 · Diabetic Neuropathy
What this study did
Phase 2 (20)
Type 1 Diabetes
NCT06238778 · Diasome Pharmaceuticals
2023-12-28 – 2025-12-16 · Diabetes Mellitus, Type 1
What this study did
NCT03682640 · Uppsala University
2018-09 – 2021-12-31 · Diabetes Mellitus, Type 1, Diabetes Mellitus, Metabolic Disease, Glucose Metabolism Disorders, Endocrine System Diseases, Juvenile Diabetes, Insulin Dependent Diabetes, Type 1 Diabetes Mellitus, Inflammation, Diet Modification
What this study did
NCT03760640 · Eli Lilly and Company
2019-02-18 – 2019-10-07 · Type1 Diabetes Mellitus
What this study did
NCT02794155 · Diasome Pharmaceuticals
2016-06 – 2018-06-15 · Type 1 Diabetes Mellitus
What this study did
NCT03156361 · Diasome Pharmaceuticals
2017-05-18 – 2018-03-15 · Type1 Diabetes Mellitus
What this study did
NCT02509429 · University Hospital, Montpellier
2015-06-16 – 2016-12 · Type 1 Diabetes
What this study did
NCT02416765 · Institut de Recherches Cliniques de Montreal
2015-05 – 2015-10 · Type 1 Diabetes
What this study did
NCT01194245 · Halozyme Therapeutics
2010-08 – 2011-08 · Diabetes Mellitus, Type 1
What this study did
NCT00883558 · Halozyme Therapeutics
2009-05 – 2010-04 · Diabetes Mellitus, Type 1
What this study did
NCT00774800 · Halozyme Therapeutics
2008-10 – 2009-03 · Type 1 Diabetes Mellitus
What this study did
Type 2 Diabetes
NCT01194258 · Halozyme Therapeutics
2010-08 – 2011-08 · Diabetes Mellitus, Type II
What this study did
NCT00747006 · Mannkind Corporation
2008-09 – 2011-05 · Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 1
What this study did
Other / comorbidity
NCT03938740 · Diasome Pharmaceuticals
2019-03-18 – 2020-03-18 · Diabetes Mellitus, Type 1
What this study did
NCT02971228 · Zealand Pharma
2016-11 – 2017-06-07 · Diabetes Mellitus, Type 1
What this study did
NCT01662921 · Sansum Diabetes Research Institute
2013-04 – 2015-08-31 · Diabetes During Pregnancy
What this study did
NCT02221323 · Profil Institut für Stoffwechselforschung GmbH
2014-09 – 2014-11 · Diabetes Mellitus
What this study did
NCT00553488 · Becton, Dickinson and Company
2007-09 – 2008-01 · Diabetes Mellitus, Type 1
What this study did
NCT01000922 · Biodel
2006-06 – 2008-01 · Diabetes Mellitus
What this study did
Phase 1/2 (2)
Phase 1 (55)
Type 1 Diabetes
NCT06280703 · Eli Lilly and Company
2024-05-15 – 2026-10-03 · Healthy, Type 1 Diabetes Mellitus
What this study did
NCT05689424 · University of California, San Diego
2025-02-01 – 2026-06-30 · Type 1 Diabetes
What this study did
NCT07090824 · Stanford University
2025-10-28 – 2026-05-29 · Diabetes Mellitus, Type 1, Type 1 Diabetes Mellitus
What this study did
NCT05262387 · Eli Lilly and Company
2022-02-14 – 2023-03-07 · Diabetes Mellitus, Type 1
What this study did
NCT05067270 · Eli Lilly and Company
2021-10-22 – 2021-12-06 · Type 1 Diabetes Mellitus
What this study did
NCT03465878 · Eli Lilly and Company
2018-03-26 – 2019-11-14 · Type 1 Diabetes Mellitus
What this study did
NCT03903016 · Sanofi
2019-03-26 – 2019-08-19 · Type 1 Diabetes
What this study did
NCT03449433 · Eli Lilly and Company
2018-03-15 – 2018-08-14 · Diabetes Mellitus, Type 1
What this study did
NCT03407118 · Eli Lilly and Company
2018-02-17 – 2018-07-12 · Diabetes Mellitus, Type 1
What this study did
NCT03341299 · Eli Lilly and Company
2017-11-13 – 2018-04-03 · Diabetes Mellitus, Type 1
What this study did
NCT02623478 · Eli Lilly and Company
2018-01 – 2018-04 · Diabetes Mellitus, Type 1
What this study did
NCT02623452 · Eli Lilly and Company
2018-01 – 2018-04 · Diabetes Mellitus, Type 1
What this study did
NCT03367390 · Eli Lilly and Company
2017-11-08 – 2018-02-09 · Type1 Diabetes Mellitus
What this study did
NCT03166124 · Eli Lilly and Company
2017-05-24 – 2017-11-18 · Diabetes Mellitus, Type 1
What this study did
NCT03056456 · Eli Lilly and Company
2017-02-23 – 2017-06-19 · Diabetes Mellitus, Type 1
What this study did
NCT02500979 · AstraZeneca
2015-08-17 – 2016-08-05 · Type 1 Diabetes Mellitus
What this study did
NCT02703324 · Eli Lilly and Company
2016-03 – 2016-08 · Diabetes Mellitus, Type 1
What this study did
NCT02703350 · Eli Lilly and Company
2016-03 – 2016-07 · Diabetes Mellitus, Type 1
What this study did
NCT01945099 · Yale University
2013-09 – 2016-07 · Type 1 Diabetes
What this study did
NCT02603510 · Sanofi
2015-11 – 2016-04 · Type 1 Diabetes Mellitus
What this study did
NCT02206568 · Perosphere Pharmaceuticals Inc, a wholly owned subsidiary of AMAG Pharmaceuticals, Inc.
2014-06 – 2014-09 · Type 1 Diabetes Mellitus
What this study did
NCT01792323 · Medical University of Graz
2011-08 – 2014-01 · Type 1 Diabetes
What this study did
NCT01811849 · Biodel
2012-08 – 2012-12 · Type 1 Diabetes
What this study did
Type 2 Diabetes
NCT06945406 · Eli Lilly and Company
2025-05-16 – 2027-07 · Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2
What this study did
NCT03170544 · Merck Sharp & Dohme LLC
2017-08-16 – 2018-11-08 · Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus
What this study did
NCT02623465 · Eli Lilly and Company
2018-01 – 2018-04 · Diabetes Mellitus, Type 2
What this study did
NCT03341312 · Eli Lilly and Company
2017-11-13 – 2018-03-31 · Diabetes Mellitus, Type 2
What this study did
NCT03286751 · Eli Lilly and Company
2017-10-13 – 2018-02-06 · Diabetes Mellitus, Type 2
What this study did
NCT03305822 · Eli Lilly and Company
2017-10-11 – 2017-12-14 · Diabetes Mellitus, Type 2
What this study did
NCT02703337 · Eli Lilly and Company
2016-03 – 2016-08 · Diabetes Mellitus, Type 2
What this study did
NCT02197520 · Eli Lilly and Company
2014-07 – 2015-06 · Diabetes Mellitus, Type 2
What this study did
Other / comorbidity
NCT03741478 · Centre for Addiction and Mental Health
2019-10-22 – 2026-06-01 · Healthy Controls
What this study did
NCT04049123 · Eli Lilly and Company
2019-11-18 – 2020-10-23 · Healthy
What this study did
NCT04235439 · Gan and Lee Pharmaceuticals, USA
2019-04-23 – 2019-07-03 · Diabetes Mellitus
What this study did
NCT02942654 · Eli Lilly and Company
2016-11 – 2016-12 · Healthy
What this study did
NCT02770521 · Eli Lilly and Company
2016-05 – 2016-07 · Healthy
What this study did
NCT02636361 · Eli Lilly and Company
2015-12 – 2016-02 · Healthy
What this study did
NCT02525744 · Eli Lilly and Company
2015-08 – 2015-10 · Healthy
What this study did
NCT02317575 · Eli Lilly and Company
2015-01 – 2015-09 · Healthy Volunteers
What this study did
NCT02293551 · Eli Lilly and Company
2014-12 – 2015-09 · Healthy Volunteers
What this study did
NCT02152384 · Eli Lilly and Company
2014-06 – 2014-12 · Diabetes Mellitus, Type 1
What this study did
NCT02111083 · Eli Lilly and Company
2014-05 – 2014-08 · Healthy Volunteers
What this study did
NCT01871493 · Eli Lilly and Company
2013-06 – 2013-09 · Healthy Volunteers
What this study did
NCT01400789 · Wockhardt
— · Bioequivalence in Healthy Subjects
What this study did
NCT01399255 · Wockhardt
2011-11 – 2012-06 · Bioequivalence in Healthy Subjects
What this study did
NCT01400802 · Wockhardt
2011-11 – 2012-06 · Bioequivalence in Healthy Subjects
What this study did
Phase 4 (43)
Type 1 Diabetes
NCT06600776 · Tel-Aviv Sourasky Medical Center
2024-10-06 – 2025-10-21 · Type 1 Diabetes (T1D)
What this study did
NCT04783376 · Sohag University
2021-04-12 – 2022-03-03 · Type 1 Diabetes Mellitus
What this study did
NCT03328845 · Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud
2017-01-20 – 2021-11-20 · Type 1 Diabetes Mellitus
What this study did
NCT03260868 · Sanofi
2017-09-19 – 2018-11-22 · Type 1 Diabetes Mellitus
What this study did
NCT02685449 · Medical University of Warsaw
2016-02 – 2018-08 · Diabetes type1
What this study did
NCT02276859 · Medical University of Warsaw
2014-10 – 2015-09 · Type 1 Diabetes
What this study did
NCT01526733 · Halozyme Therapeutics
2011-12 – 2013-09 · Type 1 Diabetes Mellitus
What this study did
NCT00505882 · University of Texas Southwestern Medical Center
2007-07 – 2008-12 · Type 1 Diabetes
What this study did
NCT00461331 · Tulane University Health Sciences Center
2004-10 – 2008-08 · Type 1 Diabetes Mellitus
What this study did
Type 2 Diabetes
NCT06370715 · Eli Lilly and Company
2024-04-18 – 2025-09-02 · Diabetes Mellitus, Type 2
What this study did
NCT05579119 · Hospital de Especialidades, Centro Medico Nacional "La Raza", Instituto Mexicano del Seguro Social
2022-07-06 – 2023-08-24 · Type 2 Diabetes
What this study did
NCT03670641 · Sandra Sobel
2019-03-26 – 2020-07-31 · Type 2 Diabetes Mellitus
What this study did
NCT01971047 · Emory University
2013-10 – 2018-09 · Type 1 Diabetes, Type 2 Diabetes
What this study did
NCT03509324 · Sun Yat-sen University
2015-03-01 – 2015-06-30 · Diabetes Mellitus, Type 2
What this study did
NCT01776788 · The First Affiliated Hospital of Xiamen University
2012-08 – 2015-02 · Diabetes Mellitus, Type 2
What this study did
NCT01159938 · Eli Lilly and Company
2010-10 – 2013-02 · Diabetes Mellitus, Type 2
What this study did
NCT01215955 · Eli Lilly and Company
2010-12 – 2013-01 · Diabetes Mellitus, Type 2
What this study did
NCT01175811 · Eli Lilly and Company
2011-02 – 2012-11 · Diabetes Mellitus, Type 2
What this study did
NCT01175824 · Eli Lilly and Company
2011-04 – 2012-11 · Diabetes Mellitus, Type 2
What this study did
NCT00971997 · Eli Lilly and Company
2009-09 – 2011-04 · Diabetes Mellitus, Type 2
What this study did
NCT00664534 · Eli Lilly and Company
2008-04 – 2010-11 · Diabetes Mellitus, Type 2
What this study did
NCT00279201 · Eli Lilly and Company
2005-12 – 2009-11 · Diabetes Mellitus, Type 2
What this study did
NCT00548808 · Eli Lilly and Company
2007-11 – 2009-08 · Type 2 Diabetes Mellitus
What this study did
NCT00841919 · Cook County Health
2006-12 – 2009-06 · Diabetes Mellitus, Type 2
What this study did
NCT00393705 · Eli Lilly and Company
2006-10 – 2009-03 · Diabetes Mellitus, Type 2
What this study did
NCT00377858 · Eli Lilly and Company
2006-08 – 2008-09 · Diabetes Mellitus, Type 2
What this study did
NCT00420095 · Eli Lilly and Company
2007-01 – 2008-01 · Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2
What this study did
NCT00191282 · Eli Lilly and Company
2002-10 – 2007-10 · Diabetes Mellitus, Type 2, Acute Myocardial Infarction
What this study did
NCT00110370 · Eli Lilly and Company
2004-04 – 2006-04 · Diabetes Mellitus, Type 2
What this study did
NCT00191464 · Eli Lilly and Company
2003-12 – 2005-09 · Diabetes Mellitus, Type 2
What this study did
NCT00191178 · Eli Lilly and Company
2003-08 – 2005-07 · Type 2 Diabetes
What this study did
NCT00551538 · Eli Lilly and Company
2003-05 – 2004-12 · Type 2 Diabetes
What this study did
Other / comorbidity
NCT04124302 · Medical University of Warsaw
2019-10-01 – 2024-12-31 · Diabetes Mellitus, Type 1
What this study did
NCT04019821 · Medical University of Warsaw
2020-01-01 – 2023-04-01 · Diabetes Mellitus, Type 1
What this study did
NCT02443714 · Chongqing Medical University
2015-04 – 2015-09 · Healthy
What this study did
NCT02165566 · University of Roma La Sapienza
2013-03 – 2014-05 · Hyperglycemia
What this study did
NCT01810952 · Baylor College of Medicine
2010-09 – 2013-09 · Hyperglycemia, Diabetes Mellitus
What this study did
NCT00985712 · Eli Lilly and Company
2009-10 – 2011-07 · Diabetes Mellitus, Type 1
What this study did
NCT01613807 · Sansum Diabetes Research Institute
2008-10 – 2010-10 · Gestational Diabetes Mellitus
What this study did
NCT02962921 · Rambam Health Care Campus
2003-02 – 2004-11 · Diabetes Mellitus, Ventricular Dysfunction
What this study did
Early phase / not applicable (25)
Type 1 Diabetes
NCT06532461 · Steno Diabetes Center Copenhagen
2024-07-20 – 2026-12-31 · Type 1 Diabetes
What this study did
NCT05660941 · Manchester University NHS Foundation Trust
2023-07-21 – 2024-05-01 · Diabetes Mellitus, Type 1
What this study did
NCT05257460 · University of Cambridge
2022-01-25 – 2023-03-25 · Type 1 Diabetes
What this study did
NCT04200313 · Jaeb Center for Health Research
2020-03-31 – 2022-01-14 · Diabetes Mellitus, Type 1 Diabetes, Diabetes Mellitus, Type 1
What this study did
NCT04031599 · Institut de Recherches Cliniques de Montreal
2020-07-10 – 2021-12-14 · Type 1 Diabetes
What this study did
NCT03890003 · Eli Lilly and Company
2019-03-28 – 2019-05-06 · Type 1 Diabetes Mellitus
What this study did
NCT03848767 · Eli Lilly and Company
2019-02-20 – 2019-04-01 · Type 1 Diabetes Mellitus
What this study did
NCT03849612 · Eli Lilly and Company
2019-02-21 – 2019-03-27 · Type 1 Diabetes Mellitus
What this study did
NCT03743285 · Eli Lilly and Company
2018-11-14 – 2019-01-28 · Type 1 Diabetes Mellitus
What this study did
NCT03102476 · University of Hull
2016-06 – 2018-02-02 · Type1diabetes
What this study did
NCT02248454 · Joslin Diabetes Center
2014-09 – 2015-04 · Type 1 Diabetes
What this study did
NCT01621776 · University of Florida
2011-06 – 2012-08 · Type 1 Diabetes
What this study did
NCT00428207 · Joslin Diabetes Center
2007-02 – 2008-08 · Type 1 Diabetes Mellitus
What this study did
Type 2 Diabetes
NCT06251635 · Centre for Addiction and Mental Health
2024-06-03 – 2026-12-31 · Insulin Resistance, Menstrual Cycle, Type 2 Diabetes, Antipsychotics
What this study did
NCT05893797 · Eli Lilly and Company
2023-10-05 – 2024-09-16 · Type 1 Diabetes, Type 2 Diabetes, Type 2 Diabetes Treated With Insulin
What this study did
NCT04484779 · Eli Lilly and Company
2020-07-14 – 2020-12-22 · Type 1 Diabetes, Type 2 Diabetes
What this study did
NCT01147627 · Sun Yat-sen University
2010-08 – 2012-12 · Diabetes Mellitus, Type 2, Newly Diagnosed
What this study did
NCT00806975 · Nagaoka Red Cross Hospital
2009-01 – 2009-06 · Diabetes Complications, Diabetes Mellitus, Type 2
What this study did
Other / comorbidity
NCT05571878 · Centre for Addiction and Mental Health
2021-09-01 – 2025-05-13 · Major Depressive Disorder, Depression
What this study did
NCT03229850 · Graydon Meneilly
2021-02-01 – 2025-04-22 · Diabetes Mellitus, Lipohypertrophy
What this study did
NCT06765655 · St. Peter's Hospital, Albany, NY
2024-04-09 – 2025-01-31 · Surgical Site Infections, Stress Hyperglycemia
What this study did
NCT01149005 · Hadassah Medical Organization
2010-06 – 2015-12 · Cystic Fibrosis, Impaired Glucose Tolerance, Pulmonary Exacerbation
What this study did
NCT01636596 · Louisiana State University Health Sciences Center Shreveport
2013-09 – 2015-01 · Alzheimer's Disease, Mild Cognitive Impairment
What this study did
NCT01213901 · University of British Columbia
2010-09 – 2014-03 · Diabetes
What this study did
NCT01045954 · Diabetes Care Center
2010-01 – 2010-10 · Diabetes Mellitus Type 1
What this study did
Used as active comparator (61)

Other programs' studies in which this drug was the registered active-comparator arm: a marker of standard-of-care status, not evidence of this drug's own progression.

Phase 3 (13)
Type 1 Diabetes
NCT07282054 · Tonghua Dongbao Pharmaceutical Co.,Ltd
2022-04-13 – 2025-01-24 · Type 1 Diabetes
What this study did
NCT02273180 · Sanofi
2014-10 – 2016-07 · Type 1 Diabetes Mellitus
What this study did
NCT00115570 · Sanofi
2005-04 – 2006-11 · Diabetes Mellitus, Insulin-Dependent
What this study did
Type 2 Diabetes
NCT05834868 · Tonghua Dongbao Pharmaceutical Co.,Ltd
2022-05-06 – 2024-12-31 · Type 2 Diabetes
What this study did
NCT04023344 · Geropharm
2018-03-14 – 2019-04-18 · Diabetes Mellitus, Type 2, Diabetes Mellitus
What this study did
NCT02294474 · Sanofi
2015-01 – 2016-02 · Type 2 Diabetes Mellitus
What this study did
NCT00348374 · Pfizer
2006-06 – 2008-08 · Diabetes Mellitus
What this study did
NCT01336751 · Sanofi
2001-07 – 2002-12 · Diabetes Mellitus, Type 2
What this study did
Other / comorbidity
NCT04254380 · Gan and Lee Pharmaceuticals, USA
2019-12-04 – 2020-01-27 · Diabetes Mellitus, Type 1
What this study did
NCT00467376 · Sanofi
2007-01 – 2008-06 · Diabetes Mellitus
What this study did
Phase 2 (6)
Type 1 Diabetes
NCT04816890 · Adocia
2021-03-23 – 2022-02-24 · Type 1 Diabetes Mellitus
What this study did
NCT01686620 · Biodel
2012-08 – 2013-06 · Type 1 Diabetes Mellitus
What this study did
Type 2 Diabetes
NCT04100473 · Dance Biopharm Inc.
2018-04-23 – 2019-08-01 · Type 2 Diabetes Mellitus
What this study did
NCT02446028 · Biodel
2015-05 – 2016-05 · Diabetes Mellitus
What this study did
Other / comorbidity
NCT03307512 · Dance Biopharm Inc.
2018-02-06 – 2019-08-30 · Safety and Tolerability
What this study did
NCT03096392 · Diasome Pharmaceuticals
2017-04-18 – 2018-03-18 · Diabetes Mellitus, Type 1
What this study did
Phase 1/2 (2)
Type 1 Diabetes
NCT02713841 · Dance Biopharm Inc.
2013-05 – 2013-07 · Type 1 Diabetes Mellitus
What this study did
Phase 1 (25)
Type 1 Diabetes
NCT04972175 · Michael Tsoukas
2021-07-28 – 2022-06 · Type1 Diabetes Mellitus
What this study did
NCT04276207 · Eli Lilly and Company
2020-02-25 – 2020-08-10 · Diabetes Mellitus, Type 1
What this study did
NCT04161976 · Eli Lilly and Company
2019-12-27 – 2020-07-14 · Diabetes Mellitus, Type 1
What this study did
NCT03916640 · Adocia
2019-01-04 – 2019-03-01 · Type 1 Diabetes Mellitus
What this study did
NCT02514954 · Adocia
2015-07 – 2015-11 · Type 1 Diabetes Mellitus
What this study did
NCT01981031 · Adocia
2013-11 – 2014-08 · Diabetes, Diabetes Mellitus, Type 1
What this study did
NCT02273258 · Sanofi
2013-03 – 2013-07 · Type 1 Diabetes
What this study did
NCT01334151 · Biodel
2011-03 – 2011-08 · Diabetes Mellitus Type 1
What this study did
NCT01201278 · Hompesch, Marcus, M.D.
— · Type 1 Diabetes
What this study did
NCT01035801 · Biocon Limited
2010-08-21 – 2011-03-12 · Type 1 Diabetes Mellitus
What this study did
Type 2 Diabetes
Other / comorbidity
NCT06153329 · Tonghua Dongbao Pharmaceutical Co.,Ltd
2021-06-17 – 2022-06-06 · Healthy
What this study did
NCT02344992 · Adocia
2015-01 – 2015-06 · Diabetes Mellitus Type 1
What this study did
NCT01638325 · Adocia
2012-07 – 2012-09 · Healthy Participants
What this study did
NCT00810589 · Medical University of Graz
2008-11 – 2008-12 · Diabetes, Type I
What this study did
Phase 4 (10)
Type 2 Diabetes
NCT03660553 · University of Miami
2018-10-10 – 2022-06-30 · Type 2 Diabetes Mellitus
What this study did
NCT03563794 · The First Affiliated Hospital of Xiamen University
2018-06-10 – 2019-12-10 · T2DM
What this study did
NCT03350984 · Universidad de Guanajuato
2017-11-02 – 2018-07-01 · Type 2 Diabetes Mellitus
What this study did
NCT02189395 · Riverside University Health System Medical Center
2013-04 – 2017-04 · Type 2 Diabetes Mellitus
What this study did
NCT02526810 · Third Affiliated Hospital, Sun Yat-Sen University
2015-07 – 2016-09 · Diabetes Mellitus, Type 2
What this study did
NCT02250794 · Rush University Medical Center
2014-10 – 2015-05 · Type 2 Diabetes Mellitus
What this study did
NCT01378117 · Emory University
2011-08 – 2012-06 · Type 2 Diabetes Mellitus, Hospitalization, Hyperglycemia
What this study did
NCT00467649 · AstraZeneca
2007-05 – 2008-04 · Type 2 Diabetes Mellitus
What this study did
Other / comorbidity
NCT02690883 · Nanfang Hospital, Southern Medical University
2016-04-08 – 2019-12-30 · Diabetic Nephropathies
What this study did
NCT00356421 · Pfizer
2006-11 – 2008-06 · Diabetes Mellitus, Type 1
What this study did
Early phase / not applicable (5)
Type 1 Diabetes
NCT06948760 · Mark D. DeBoer, MD, MSc., MCR
2025-07-23 – 2026-03-10 · Type 1 Diabetes
What this study did
NCT05508061 · Inreda Diabetic B.V.
2022-10-19 – 2023-03-16 · Type 1 Diabetes
What this study did
Other / comorbidity
NCT07171684 · Rutgers, The State University of New Jersey
2025-11-26 – 2027-05-15 · Diabetes in Pregnancy, Gestational Diabetes
What this study did
NCT03606018 · Geropharm
2017-04-12 – 2017-07-13 · Clamp Study
What this study did
NCT03604575 · Geropharm
2016-08-22 – 2016-12-26 · Clamp Study
What this study did
Appears in other studies (8)

Studies that reference this drug without giving it an intervention arm of its own: other formulations' programs, background therapy, or registry-search bleed.

Phase 3 (1)
Type 2 Diabetes
NCT00551356 · Eli Lilly and Company
2002-11 – 2003-07 · Diabetes Mellitus Type 2
What this study did
Phase 4 (5)
Type 2 Diabetes
NCT03320031 · Yanbing Li
2017-06-03 – 2019-12 · Type 2 Diabetes Mellitus, Peritoneal Dialysis
What this study did
NCT02556918 · Emory University
2016-01 – 2018-11-06 · Hyperglycemia
What this study did
Other / comorbidity
NCT07109245 · Centre for Addiction and Mental Health
2025-12-11 – 2028-12 · Brain Insulin Sensitivity, Healthy Controls, Cognition
What this study did
NCT02741687 · Emory University
2016-06 – 2017-04 · Hyperglycemia
What this study did
NCT02443402 · Emory University
2016-01 – 2016-12 · Coronary Artery Disease
What this study did
Early phase / not applicable (2)
Type 1 Diabetes
NCT01531855 · Northumbria University
2012-02 – 2012-08 · Type 1 Diabetes
What this study did
Other / comorbidity
NCT00464854 · Assaf-Harofeh Medical Center
2005-07 – 2006-09 · Diabetes Mellitus
What this study did

Competitive landscape

This mechanism is crowded: 8 other tracked programmes target it, none of them ahead of this one.

This drug's own stage for Type 1 Diabetes: Approved. Competitors below are sorted furthest-along first.

DrugStageModalityMechanismEvidence signalReported efficacygraded featured trials
Insulin Lispro (Humalog): this drugApprovedPeptideInsulin receptornot yet gradedNo reviewed efficacy summary in this indication
AfrezzaApprovedPeptideInsulinPartial signal
NCT04974528: HbA1c change at week 26 (ITT, n=117 vs 113): Afrezza +0.19 vs rapid-acting insulin analog +0.01; difference 0.18 percentage points (95% CI -0.07 to 0.44); non-inferiority (0.4% margin) not met, one-sided adjusted p=0.058. missed
NCT01445951: Change in HbA1c from baseline to week 24 (LS mean): Technosphere Insulin (Gen2 inhaler) plus basal insulin -0.21% vs insulin aspart plus basal insulin -0.40%; difference 0.19% (95% CI 0.02 to 0.36), inside the pre-specified non-inferiority margin of 0.4% (CT.gov posted analysis).
Insulin Aspart (NovoLog)ApprovedPeptideInsulin receptornot yet gradedNo reviewed efficacy summary in this indication
Insulin Aspart (Fiasp)ApprovedPeptideInsulin receptornot yet gradedNo reviewed efficacy summary in this indication
Insulin Degludec (Tresiba)ApprovedPeptideInsulin receptor (basal)not yet gradedNo reviewed efficacy summary in this indication
Insulin Detemir (Levemir)
ApprovedUS marketing discontinued
PeptideInsulin receptor (basal)not yet gradedNo reviewed efficacy summary in this indication
Insulin Glargine (Lantus)ApprovedPeptideInsulin receptor (basal)not yet gradedNo reviewed efficacy summary in this indication
Insulin Glargine (Basaglar)ApprovedPeptideInsulin receptor (basal)not yet gradedNo reviewed efficacy summary in this indication
Insulin Glargine (Toujeo)ApprovedPeptideInsulin receptor (basal)not yet gradedNo reviewed efficacy summary in this indication
Insulin Glulisine (Apidra)ApprovedPeptideInsulin receptornot yet gradedNo reviewed efficacy summary in this indication
Insulin HumanApproved—Insulinnot yet gradedNo reviewed efficacy summary in this indication
Insulin Lispro (Lyumjev)ApprovedPeptideInsulin receptornot yet gradedNo reviewed efficacy summary in this indication
Insulin NPH (Humulin N)ApprovedPeptideInsulin receptornot yet gradedNo reviewed efficacy summary in this indication
Pramlintide (Symlin)
ApprovedUS marketing discontinued
PeptideAmylin receptornot yet gradedNo reviewed efficacy summary in this indication
CadisegliatinPhase 3Small moleculeGlucokinasenot yet gradedNo reviewed efficacy summary in this indication
Sotagliflozin (Inpefa)Phase 3Small moleculeSGLT1/2 (dual)not yet gradedNo reviewed efficacy summary in this indication
ZimislecelPhase 3Cell therapyPancreatic islet cells (VX-880 is a stem cell-derived therapy, not a small molecule drug), Pancreatic islet cell replacementnot yet gradedNo reviewed efficacy summary in this indication
IcovamenibPhase 2Small moleculeMeninnot yet gradedNo reviewed efficacy summary in this indication

Upcoming events

(3 total)

Estimated primary-completion dates from ClinicalTrials.gov. These are registry estimates, never confirmed readout dates; they can move as trials progress.

Follow Humalog (Insulin Lispro) to get an email as a readout nears, when a date moves, or when a study changes status. Needs a free account.

Add these readouts to your calendar: Apple or Outlook · Google Calendar · .ics link. The calendar updates when a registry date moves.

2026 (2)
December 2026 (2)
Early phase / not applicableType 1 DiabetesRecruiting
Est. primary completion 2026-12-31 · NCT06532461 · CT.gov ↗
What to watch
Early phase / not applicableType 2 DiabetesActive not recruiting
Est. primary completion 2026-12-31 · NCT06251635 · CT.gov ↗
What to watch
2027 (1)
July 2027 (1)
Phase 1Type 2 DiabetesRecruiting
Est. primary completion 2027-07 · NCT06945406 · CT.gov ↗
What to watch

See the full readout calendar ↗